Advertisement

Topics

WaferGen Bio-systems to Announce Second Quarter 2015 Financial Results on Wednesday, August 5

20:00 EDT 26 Jul 2015 | Globe Newswire

FREMONT, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS) announced today that it will announce second quarter ended June 30, 2015 financial results after the market close and host a conference call and webcast on Wednesday, August 5, 2015.

Conference Call & Webcast
Wednesday, August 5, 2015 @ 5:00pm Eastern Time
Domestic: 877-407-3982
International: 201-493-6780
Conference ID: 13615473
Webcast: http://public.viavid.com/player/index.php?id=115605
   
Replays available until August 19, 2015
Domestic:  877-870-5176
International: 858-384-5517
Passcode:  13615473

About WaferGen

WaferGen Bio-systems, Inc. is a life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesign™ Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TE™ System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Seq-Ready™ TE System, powered by SmartChipTM massively-parallel singleplex PCR technology, is an innovative one-step target enrichment and library preparation solution. The Company now also offers the Apollo 324™ product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster and cheaper genetic analysis based on Next-Gen Sequencing and Real-Time PCR. In addition, WaferGen has established proof-of-concept for its single cell technology, which is based on the Company's SmartChip™ platform. WaferGen's scientists have successfully isolated single cells and produced excellent results in downstream processing of these individual cells, including RNA sequencing.

For additional information, please see http://www.wafergen.com

CONTACT: INVESTOR CONTACTS:
         
         LifeSci Advisors, LLC
         Brian Stollar
         bstollar@lifesciadvisors.com
         
         WaferGen Bio-systems, Inc.
         Rollie Carlson
         Rollie.carlson@wafergen.com
NEXT ARTICLE

More From BioPortfolio on "WaferGen Bio-systems to Announce Second Quarter 2015 Financial Results on Wednesday, August 5"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...